NEURODEGENERATIVE DISEASES AND ASPARTAME

 

REFERENCES

Adam, E. (2004). A talk given at the sheridan holistic health fair, what does it mean to be born in america today? Vaccination Liberation, Retrieved December 20, 2004, from http://www.vaclib.org/chapter/lecture2.htm

Affidavit of Norma Vera, )2004 September 1) with permission from Dr. Betty Martini. Document received January 2005.

Anitei, S. (2006). Common protein found in dementia and sclerosis; this adds to the understanding of the neurodegenerative conditions. Sofepedia, Science Retrieved May 9, 2007, from http://news.softpedia.com/news/Common-Protein-Found-in-Dementia-and-Sclerosis-37318.shtml

Barua, J. & Bal, A. (1995). Emerging facts about aspartame. Journal of the Diabetic Association of India, 35(4), Retrieved June 16, 2007, from http://www.wnho.net/ emerging_aspartame_facts.htm

Beneveniste, H., Drejer, J.,Schousboe, A., & Diemer, N.H. (1984). Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. Journal of Neurochemistry1984 Nov;43(5):1369-74 Retrieved May 23, 2007, from http://www.ncbi.nlm.nih.gov/entrez/ query.fcgi?db=PubMed&cmd=Retrieve&list_uids=6149259&dopt=Citation

Blaylock, R.L. (1997). Excitotoxins, the taste that kills: The taste that kills.Santa Fe: Health Press.

Blaylock, R. L. (1997). Exciting cells to death. excitotoxins: the taste that kills. Santa Fe: Health Press

Blaylock, R L. (1997). Creeping death: the neurodegenerative diseases. excitotoxins: The taste that kills. Santa Fe: Health Press.

Blaylock, R.L. (1999). Food additive excitotoxins and degenerative brain disorders. Medical Sentinel 1999;4(6), 212-215.Association of American Physicians and Surgeons (AAPS). Retrieved May 4, 2007, from http://www.whale.to/a/blaylock5.html

Blaylock, R.L. (2000). Aspartame, MSG and other excitotoxins and the hypothalamus. Retrieved January 20, 2004, fromhttp://www.dorway.com/hypot.txt

Blaylock, R.L. (2000). Excitotoxins, neurodegeneration, neurodevelopment, migraines, & seizures. Medical Sentinel Magazine by the Association of American Physicians and Surgeons, Inc. (AAPS). Retrieved from Sightings on April 20, 2007, from http://www .rense.com/politics6/excito.htm

Blaylock, R.L. (2003). The central role of excitotoxicity in autism spectrum disorders. The Journal of the American Nutraceutical Association 6, No. (1)– Retrieved July 7, 2007, from http://www.dorway.com/blayautism.txt

Blaylock, R.L. (2004). The connection between MS And aspartame. Retrieved June 3, 2007, from, http://www.rense.com/general53/ms.htm

Blaylock, R.L.(2005). Vaccines, autism and gulf war syndrome. Retrieved May 18, 2007, from http://www.rense.com/general67/vacc.htm

Blaylock, R.L. (2006). Not just another scare: Toxin additives in your food and drink, Retrieved May 16, 2007, from http://www.Aspartame.com/blayart1.htm

Brace, H. Latimer, M. & Winn, P, (1997). Neurotoxicity, blood-brain barrier breakdown, demyelination and remyelination associated with NMDA-induced lesions of the rat lateral hypothalamus. Brain Res Bull. 1997;43(5):447-55. School of Psychology, University of St. Andrews, St. Andrews, Fife, KY16 9JU, Scotland, ROYAUME-UNI. Retrieved June 3, 2007, from http://www.ncbi.nlm.nih.gov/sites/ entrez?cmd=Retrieve&db=PubMed&list_uids=9250618&dopt=Abstract

Brannigan, V., (1983). The first FDA board of inquiry: the aspartame case, law and science in collaboration, edited by J.D. Nyhart and Milton M.Carrow, Lexington Books, D.C. Heath and Company, Lexington, Massachusetts, c1983, (pp.181-210)

Bressler, J, (1977). Div G.D. Searle & Co., The Bressler Report. This is the text of an FDA report on Searle

Bowen, J. (2000). Aspartame murders infants violates federal genocide law. Betty Martini, Mission Possible International 770 242-2599. Retrieved May 11, 2007, from http://www.dorway.com.

Bowen, J., & Evangelista, A.M. (2002). Brain cell damage from amino acid isolates: a primary concern from aspartame-based products and artificial sweetening agents – nutrasweet~equal~ "sugar free"~neotame. Retrieved May 11, 2007, from http://www .wnho.net/Aspartame_brain_damage.htm

Bowen, J.D. (2002). Amino acid isolates: note info on aspartame and Parkinson’s. (letter to: Oprah; Michael J. Fox and Parkinson's) http://www.dorway.com

Bowen, J.D. (2005) Aspartame devastation. world natural health organization. Retrieved February 16, 2007, from http://www.wnho.net/Aspartame_devastation.htm

Breitner, J.C., Gau, B.A, Welsh, K.A., Plassman, B.L., McDonald, W.M., Helms, M.J., et al. (1994). Inverse association of anti-inflammatory treatments and Alzheimer's disease: initial results of a co-twin control study. Neurology, 44(2),227-232

Budavari, S. (Ed.) (1989). The Merck index. An encyclopedia of chemicals, drugs, and biologicals. 11th ed. Merck and Co. Inc., Rahway, NJ.

Buzzard, J. A. (1976a) Testimony of James A. Buzzard, G.D. Searle, before the U.S. Senate Joint Hearings before the Subcommittee on Health of the Committee on Labor and Public Welfare and the Subcommittee on Administrative Practice and Procedure of the Committee on the Judiciary, Preclinical and Clinical Testing by the Pharmaceutical Industry, 1976, Part 2, No. Y4.L11/2:P49/2/976/pt2, CIS# S541-82, pp.168.

Buzzard, J. A. (1976b). Letter from James A. Buzzard of G.D. Searle to Dr. Alexander M. Schmidt, Commissioner, U.S. Food and Drug Administration, January 7, 1976, "Good Laboratory Practices" proposal enclosure, Reprinted in U.S. Senate Joint Hearings before the Subcommittee on Health of the Committee on Labor and Public Welfare and the Subcommittee on Administrative Practice and Procedure of the Committee on the Judiciary, Preclinical and Clinical Testing by the Pharmaceutical Industry, 1976, Part 2, No. Y4.L11/2:P49/2/976/pt2, CIS# S541-82, pp. 185-213.

Calne, D.B., Michael, D. M., & Zigmond, J. (1991). Compensatory mechanisms in degenerative neurologic disease: Insights from Parkinsonism. Archive Neurology 1991 Apr;48(4): pp.361-363 Retrived May 8, 2007, from http://www.ncbi.nlm.nih.gov/entrez/ query.fcgi?cmd=Retrieve&db=PubMed&list_uids=2012508&dopt=Abstract

Cherniske, S. A. (2003) The metabolic plan. Ballantine Publishing Group, 1540 Broadway New York, NY 10036 Chapter 3, pp.3-5

Christopherson, K.S., & Bredt, D.S. (1997). Nitric oxide in excitable tissues: Physiological roles and disease. Journal of Clinical Investigation, 100, (pp. 2424-2429) Departments of Physiology, University of California at San Francisco, San Francisco, California 94143

Choi, D. W. (1988). Glutamate neurotoxicity and diseases of the nervous system, Neuron, 1(8), 623-34

Choi, D. W. (1989). Glutamate neurotoxicity, calcium and zinc. Annals of the New York Academy of Science. 568, 219-224

Choi, D. W. (1990). Glutamate Neurotoxicity: A three-stage process. In Neurotoxicity of Excitatory Amino Acids.FIDA Research Foundation symposium Series, Vol. 4, edited by A. Guidotti, New York: Raven Press., pp. 235-242

Cloninger, M.R., R.E. Balwin (1970). Aspartylphenylalanine methyl ester: a low calorie sweetener, Science, 170, 81.

Coyle J.T., Bird S.J., Evans R.H., Gulley R.L., Nadler J.V., & Nicklas W.J., et al. (1981). Excitatory amino acid neurotoxins: selectivity, specificity, and mechanisms of action. Neuroscience Research Program Bulletin 19, 331-427.

Congressional Record-Senate (1985). Aspartame safety act of 1985. August 1, 1985, pp.S10820-10847

Cooper, J. M., & Schapira, A. H. V. (1997). Mitochondrial dysfunction in neurodegeneration. Journal of Bioenergetics and Biomenbranes. Springer Netherlands. 2 (10).1023/A:1022642114734 (pp.175-183) Retrieved May 26, 2007, from http://www .springerlink.com/content/j761m4384447h871/

DeBoni, U. & Crapper-McLachlan, D.R. (1978). Paired helical filaments of the Alzheimer type in cultured neurons. Nature, February; 271, 566 – 568. Retrieved May 16, 2007, from http://www. nature.com/nature/journal/ v271/n5645/abs/ 271566a0.html

DeBoni, U. & McLachlan, D.R. (1985). Controlled induction of paired helical filaments of the Alzheimer type in cultured human neurons, by glutamate and aspartate. Journal of Neurology Science 1985 May; 68 (2-3),105-18

Department of Health & Human Services (DHHS) (1993). Adverse reactions associated with aspartame consumption April 1, 1993 (HFS-728). Chief, Epidemiology Branch. Retrieved September 8, 2007 from, http://en.wikipedia.org/wiki/Aspartame_controversy

Dosch, H.M. & Becker, D. J. (2000). Measurement of T cell autoreactivity in autoimmune diabetes. Diabetologia 43:386

Dosch, H.M. (2006). Diabetes breakthrough.Toronto scientists cure disease in mice. Tom Blackwell, National Post. Published: Friday, December 15, 2006. Retrieved December 17, 2006, from http://www.canada.com/nationalpost/news/ artslife/torontomag/ story.html?id=a042812e-492c-4f07-8245-8a598ab5d1bf&k=63970

Duara, R., Grady, C. Haxby, J., Ingvar, D., Sokoloff, L., Margolin, R.A, et al. (1984).Human brain glucose utilization and cognitive function in relation to age. Annals of Neurology. December; 16 (6) (pp.703-13) Retrieved May 13, 2007, from http://www.ncbi.nlm.nih.gov/entrez/query .fcgi?cmd=Retrieve&db=PubMed&list_uids=6335379&dopt=Abstract

DHHS (1993). Methanol Toxicity, American Family Physician, 71(1), 163-171, January 1993. Adapted from Case Studies in Environmental Medicine published by the Agency for Toxic Substances and Disease Registry, U.S. Department of Health and Human Services.

Eisen, A. (2000). Amyotrophic lateral sclerosis (ALS): The diagnosis and treatment of this debilitating disease. Geriatrics and Aging.November, 3(9), 26-27 Retrieved February 20, 2007, from http://www.als.ca/if_you_have_als/ als_introduction_diagnosis.aspx?print=1&

Evangelista, A. (2004). Aspartame: the history of a killer - the whole story. Retrieved December 10, 2006, from http://www.rense.com/general50/KILLER.HTM

Evangelista, A. (2004). The history of aspartame. Modified and additional material by Arthur M. Evangelista, a former FDA investigator. Original Authors of the Two Main Components: Alex Constantine and Gregory Gordon. Retrieved February 25, 2007, from http://www.wnho.net/history_of_aspartame.htm

Evangelista, A (2005). Sweet misery documentary – Sound and Fury Productions. 2301 East Broadway, Suite 111,Tucson, AZ. 85719, Phone: 520-624-9710, Fax: 520-624-3143
cori@soundandfury.tv

Farber, S. A. (1989). Aspartame and the Regulation of Food Additives: A Study of FDA Decision-Making and a Proposal for Change. Master of Science in Technology and Public Policy Thesis at Massachusetts Institute of Technology, Cambridge, MA 02139.

Farooqui, A.A., Horrocks, L.A. (1998). Lipid peroxides in the free radical pathophysiology of brain diseases. Cellular and Molecular Neurobiology. Springer Netherlands, December, 18 (6) 599-608

Federal Drug Administration (1995). Symptoms attributed to aspartame in complaints submitted to the FDA. Department of Health and Human Services April 20, 1995.

Federal Register (1973). Notice of filing of food additive petition, G.D.Searle & company.

(38), 5,921.

Federal Register (1974). (39), 27137

Federal Register (1975). (40), 56907

Federal Register (1979). "Ruling on objections and notice of Hearing before a public board of inquiry; aspartame," (44), 31-717

Freeman, Martha (1973). Memorandum from Martha A. Freeman, Supervisory medical officer, FDA division of metabolic and endocrine drug products to Dr. C.J. Kokosi, FDA

division of toxicology, September 12, 1973, Reprinted in US Senate 1987, (pp. 326-336). Retrieved June 13, 2007, from http://www.holisticmed.com/Aspartame/history.faq.

Food Chemical News, June 12, 1995, Page 27. Retrived on September 8, 2007, from http:// en .wikipedia.org/wiki/Aspartame_controversy

Furia, T.E. (1972). CRC Handbook of food additives. 2nd ed., Cleveland, Ohio: (pp. 193.) CRC Press.

Gold, M. (1995). The bitter sweet truth about artificial sweeteners. Blazing Tattles, 4, (4, 5, 6) April-June. P.O. Box 8609, Tampa, FL 33674-8609, USA. Claire W. Gilbert, Publisher & Editor Blazing Tattles. http://www.blazingtattles.com

Gold, M. (2002). Scientific abuse in Parkinson's disease research related to aspartame. Aspartame Toxicity Information Center, 12 East Side Dr., Suite 2-18 Concord, NH 03301. 603-225-2110. Retrieved May 13, 2007 from, http://www.fda.gov/OHRMS/DOCKETS/dailys/03/ Jan03/012203/02P-0317_emc-000201.txt

Gordon, G. (1987). NutraSweet: questions swirl. UPI Investigative Report, 10/12/87. Reprinted in US Senate (pp.483-510). Retrieved May 3, 2007, from http://www.holisticmed.com/ Aspartame/history.faq

Graves, F. (1984). How safe is your diet soft drink, Common Cause Magazine, July/August 1984. Reprinted in Congressional Record 1985a, S5497-S5506. Retrieved August 19, 2007, from http://www.dorway.com/nutrapoison2.html

Gross, A. (1975). Memorandum from Mr.Adrian Gross, scientific investigations staff to Mr. Carlton Sharp, Chairman, Searle investigation task force, September 29, 1975, Reprinted in U.S. Senate Joint Hearings before the Subcommittee on Health of the Committee on Labor and Public Welfare and the Subcommittee on Administrative Practice and Procedure of the Committee on the Judiciary, "Preclinical and Clinical Testing by the Pharmaceutical Industry, Part 1," No. 4.L11/2:P49/2/975, CIS# S541-16, (pp. 440). Retrieved September 6, 2006 from, http://www.holisticmed.com/Aspartame/

history.faq.

Gross, A. (1976). Congressional Record of the US Senate. Page 333

Gross, Adrian, (1987). Letter from Dr. Andrian Gross. Former FDA investigator and scientist to Senator Howard Metzenbaum regarding pre-approval tests by G.D. Searle, November 3, 1987, Reprinted in US Senate 1987, (443-453). Retrieved on July 14, 2007, from http://www.holisticmed.com/Aspartame/history.faq

Gough, V. M, Kyriakides, Herbert, C., Hechtman, B. (2006). Molecular and cellular mediators of the inflammatory response: Introduction. Medscape Today, From ACS Surgery Online. Retrieved June 15, 2007 from, http://www.medscape.com/viewarticle/535499

Hauta, W.J.H., Lampert, P.W., & Young, V.R. (1980) Aspartame public board of inquiry. department of health and human services. FDA (Docket No. 75P-355) Aspartame – Decision of the Public Board of Inquiry. Retrieved July 29, 2007, from http://www.dorway.com/pboi.txt

Helling, Herbert, (1970). Memorandum from Herbert Helling, G.D. Searle Official to several G.D. Searle Officials, regarding Food and Drug Sweetener Strategy, December 28, 1970, Reprinted in U.S. Senate Joint Hearings before the Subcommittee on Health of the Committee on Labor and Public Welfare and the Subcommittee on Administrative Practice and Procedure of the Committee on the Judiciary, "Preclinical and Clinical Testing by the Pharmaceutical Industry, 1976, Part 2," No. Y4.L11/2:P49/2/976/pt2, CIS# S541-82, (16-19.) Retrieved May 8, 2007, from http://www.holisticmed.com/ Aspartame2/aspart.p20a.

Indakoetxea, B., Lopez de Munain, A., Marti-Masso, J.F., & Linazasoro, G. (1990). Parkinsonism after methyl alcohol poisoning. Neurologia Aug-Sep; 5 (pp.238-241). Retrieved July 12, 2007, from http://www.ncbi.nlm.nih.gov/sites/ entrez?cmd=Retrieve&db=PubMed&list_uids=2288753&dopt=AbstractPlus.

Journal Neurological Science (1999). Guamanian neurodegenerative disease: electrophysiologic findings, 166 (1), 28-35. PMID: 10465496 [PubMed - indexed for MEDLINE]

Kleckner, N.W., & Dingledine, R. (1988). Requirement for glycine in Activation of NMDA receptors expressed in xenopus oocytes. Sceince 241, 835-837. Retrieved February 9, 2007, from http://www.sciencemag.org/cgi/content/abstract/241/4867/835.

Kennedy, Edward M. (1976). Testimony of U.S. Senator Edward M. Kennedy at the U.S. Senate joint hearings before the subcommittee on health of the committee on labor and public welfare and the subcommittee on administrative practice and procedure of the committee on the judiciary, "Preclinical and Clinical Testing by the Pharmaceutical Industry, Part 3," No. Y4.L11/2:P49/2/976/pt.3,CIS# S541-12. Retrieved April 27,2007 from, http://www.holisticmed.com/Aspartame2/aspart.p20a.

Kavet, R. & Nauss, K. M. (1990). The toxicity of inhaled methanol vapors. Critical Reviews in Toxicology, 21, (1), 21-50.

Kish, S.J., Bergeron, C., Rajput, A., Dozic, S., Mastrogiacomo, F., & Chang, L.J., et.al. (1992). Brain cytochrome oxidase in Alzheimer's disease. Journal of Neurochemistry 776-779. Human Neurochemical Pathology Laboratory, Clarke Institute of Psychiatry, Toronto, Ontario, Canada.

Kostera-Pruszczyk, A., Niebroj-Dobosz, I,. Emeryk-Szajewska, B., Karwańska, A., & Rowińska-Marcińska, K. (2002).Motor unit hyperexcitability in amyotrophic lateral sclerosis vs amino acids acting as neurotransmitters, Acta Neurologica Scandinavica. 106 (1) 34. Retrieved August 4, 2007 from, http://www.blackwell-synergy.com/ doi/abs/10.1034/j.1600-0404.2002.00149.x?journalCode=ane

Kurland, L.T. (1988). Amyotrophic lateral sclerosis and Parkinson’s disease complex on Guam linked to an environmental neurotoxin. Trends in Neurosciences. (11) 51-54. Retrieved May 6, 2007 from, http://www.ncbi.nlm.nih.gov/sites/entrez

Lai, J.C.K., DiLorenzo, J.C., Sheu, & Rex, K.F. (1988). Pyruvate dehydrogenase complex is inhibited in calcium-loaded cerebrocortical mitochondria. Neurochemical Research, Springer Netherlands 13, (11). Retrieved May 26, 2007, from http://www. springerlink.com/content/u272v66781522876/

Lindvall, O., Auer R. N., & Siesjö B. K. (1988). Mechanisms of hypoglycemic brain damage. Experimental Brain Research Journal. Springer Berlin/Heidelberg.73, (1) 0014-4819.

Retrieved May 23, 2007, from http://www.springerlink.com/content/p02742534n170nm2/

Liesivuori, J. & Savolainen, H. (1991). Methanol and formic acid toxicity: Biochemical Mechanisms, Pharmacology & Toxicology, (69), 157-163. Retrieved June 20, 2007, from http://www.dorway.com/offasprt.html.

Lipton, S. & Rosenberg, P. (1994) Excitatory amino acids as a final common pathway for neurologic disorders New England Journal of Medicine (330), 613-22.

Lucas, D. R. & Newhouse, J. P. (1957). The toxic effect of sodium l-glutamate on the inner layers of the retina. Archives of Ophthalmology, (58), 193-201.

Lynch, D. R. & Guttman, R.P. (2002). Excitotoxicity: Perspectives based on N-Methyl-D-aspartate receptor subtypes. The Journal of Pharmacology and Experimental Therapeutics. 300, (3), 717-723.

Martini, B. (2003). The case for aspartame disease being gulf war illness, Lou Gehrig. Mission Possible International, Duluth, Georgia. Retrieved April 30, 2006, from http://wnho.net/Aspartameandgulfwar.htm

Martini, B. (2005). Aspartame interacts with all drugs, vaccines and toxins. Mission Possible International, Duluth, Georgia. Retrieved March 1, 2007, from http://www.wnho.net/ Aspartame_interacts.htm

Martini, B (1995). Is Desert Storm syndrome NutraSweet disease.Mission Possible International, Duluth, Georgia. Retrieved December 2006, from http://www.dorway.com/ betty/deserts.txt

Martini, B. (2000). Parkinson's disease, Michael Fox, MS and the aspartame story. Mission Possible International. Retrieved September 2003, from http://www.rense.com/

general21/parkinsonFox.htm

Martini, B. (2003).Evidence for aspartame triggered brain tumors. Betty Martini's debate with Dr. R. Fink on Brain Tumor List. Retrieved July 28, 2007, from http://www.rense.com/ general35/evid.htm

Martini, B. (2005). Alabama board of education meeting today – crucial aspartame/pop warning. Mission Possible International, 9270 River Club Parkway Duluth, Georgia 30097
Telephone: 770-242-2599 Retrieved June 9, 2007 from, http://www.wnho.net/ alabama_boe_meeting.htm

Martini, B. (2006). Letter to Schwarz pharma – Remove aspartame from the Parkinson drug, Parcopa, it can precipitate the disease! - Mission Possible International, 9270 River Club Parkway Duluth, Georgia 30097 Telephone: 770-242-2599 Retrieved August 18, 2007 from, http://www.wnho.net/schwarz_pharma_letter.htm

Martini, B. (2007). Does aspartame multiply female MS – new study report at neurology conference.BolenReport.net. May 7, 2007. Retrieved June 3, 2007, from http://www.bolenreport.net/feature_articles/feature_article062.htm

Martini, B. (2007). Open letter to Laura Tarantino of FDA. Why are you lying about aspartame? Retrieved July 7, 2007, fromhttp://www.wnho.net/ open_letter_to_laura_tarantino_fda.htm

Massachusetts Medical Society (1984). Reported Aspartame-associated neurological effects reported. MMS Headquarters, 860 Winter Street Waltham Woods Corporate Center Waltham, MA 02451-1411

Mattson, M.P. (1990). Antigenic changes to those seen in neurofibrillary tangles are elicited by glutamate and Ca+2 influx in cultured hippocampal neurons. Neuron (2),105-117

Mattson, M.P., Cheng ,B., Davis, D, Bryant, K, Lieberburg, I., & Rydel, R.E.(1992). Beta-amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. Journal of Neuroscience, (12), 376-389, Society for Neuroscience. Retrieved May 22, 2007, from http://www.jneurosci.org/cgi/ content/abstract/12/2/376 and http://www.jneurosci.org/cgi/reprint/12/4/1558

Mazur, R. H., Schlatter, J., & Goldkemp, A. (1969). The structure-taste relationship of some dipeptides. Journal of the American Chemical Society, 91, (2), 684.

McLin, J.P. Thompson, L.M., & Steward, O. (2006). Differential susceptibility to striatal neurodegeneration induced by quinolinic acid and kainate in inbred, outbred and hybrid mouse strains. European Journal of Neuroscience 24 (11), 3134-3140. Retrieved June 15, 2007, from http://www.ncbi.nlm.nih.gov/sites/ entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17156374&ordinalpos=3&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum

Merrill, R. (1977). Congressional Record of the US Senate.

Monaghan, D.T., Bridges, R.J., & Cotman, C.W. (1989). The excitotory amino acid receptores: Their classes, pharmacology, and distinct properties in the function of the central nervous system. Annual Review of Pharmacology and Toxicology (29), 365-402

Monje, M. L. & Palmer, T. (2003). Radiation injury and neurogenesis Developmental disorders. Current Opinion in Neurology. 16(2):129-134.

Monte, W. C. (1984). Aspartame: Methanol and the public health, Journal of Applied Nutrition, 36, (1), 42-54.

Monte, W. C. (1984). Aspartame: Methanol and the Public Health,Journal of Applied Nutrition, 36, (1), 44. Retrieved May 26, 2007, from http://www .sweetmiserydvd.com/

Maragos, W.F., Greenamyre, J.T., Penny, J. B., & Young, A. B. (1987).Glutamate dysfunction in Alzheimer’s disease: An hypothesis. Trends in Neurosciences, 10, (2), 65-68.

Mullarkey, B., (1994). How Safe Is Your Artificial Sweetner? Account of John Cook as published in Informed Consent Magazine. September/October 1994. Available from Informed Consent Magazine, P.O. Box 935, Williston, ND 58802-0935, 701/859-3002. Available from NutriVoice, P.O. Box 946, Oak Park, Illinois 60303, (708) 848-0116.

Murray, R. (2005). Eyelid contact dermatitis by formaldehyde from aspartame. Room For All, 1943 Otowi Road,,Santa Fe, New Mexico 87505 USA,Telephone: 505-501-2298. Retrieved May 26, 2007, from http://www.wnho.net/dermatitis_from_Aspartame.htm

Murray, R. (2005). Formaldehyde & formic acid from 11% methanol in aspartame. Room For All, 1943 Otowi Road,,Santa Fe, New Mexico 87505 USA. Telephone: 505-501-2298. Retrieved May 26, 2007, from http://www.wnho.net/ formaldehyde_methanol_Aspartame.htm

Mutisya, E. M., Bowling, A., & Beal, M. F. (1994). Cortical cytochrome oxidase activity is reduced in Alzheimer's disease. Journal of Neurochemistry 63 (6), 2179–2184. Retrieved May 26, 2007, from http://www.blackwell-synergy.com/doi/abs/10.1046/j.1471-4159.1994.63062179.x?journalCode=jnc

Naira, A.C., Hemmings Jr., H.C., & Greengard, P. (1985). Protein kinases in the brain. Annual review of biochemistry (54), 931-976. Retrieved June 14, 2007, from http://www. arjournals.annualreviews.org/doi/pdf/10.1146/annurev.bi.54.070185.004435

National Institute of Neurological Disorders and Stroke (2005). Parkinson's disease: A research planning workshop. Retrieved June 15, 2007, from http://www.ninds.nih.gov/ news_and_events/proceedings/parkinson_workshop_proceeding.htm#Excitotoxicity

Neurological Channel (2007). Epilepsy and seizures: The physiology of a seizure. Retrieved June 6, 2007, from http://www.neurologychannel.com/seizures/

Olney, J.W. (1969) Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate. Science Magazine, May 719-721

Olney, John W. & Oi-Lan, Ho (1970). Brain damage in infant mice following oral intake of glutamate, aspartate or cysteine. Nature, (227), 609-610.

Olney, J.W. (1980). Aspartame board of inquiry prepared statement. Washington University School of Medicine St. Louis, MI

Olney, J.W., Labruyere, J., & De Gubareff, T. (1980). Neurobehavioral toxicology, brain damage in mice from voluntary ingestion of glutamate and aspartate. National Center for Biotechnology Information (2), 125-129. Retrieved June 9, 2007, from: http://www.ncbi.nlm.nih.gov/entrez/ query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7290308&dopt=Abstract

Olney, J. W. (1996). Dr. John Olney on brain tumors and aspartame, part 1,2,3. Researchers call for further studies after identifying a possible link between aspartame and brain tumors. Retrieved December 20, 2007, from http://www.bio.net/bionet/mm/immuno/1997-March/009832.html

Washington University School of Medicine, St. Louis. Retrieved on July 7, 2007 from, http://www.dorway.com/betty/olneyup1.html and http://www.dorway.com/betty/olneyup1.html

Osterloh, J.D. & Holmes, J. R. (1995). Neurological effects of low-level Methanol exposure. University of California at San Francisco. This research was conducted under contract with the University of California at San Francisco (ARB Contract No. A033-172).

Packer, L. & Colman, C. (1999). The antioxidant miracle: Your complete plan for total health and healing. John Wiley & Sons, Inc.

Parker, W. D., Filley, C.M., & Parks, J.K. (1990). Cytochrome oxidase deficiency in Alzheimer's disease. Neurology, 40(8), 1302-1303. Retrieved May 25, 2007, from http://www.ncbi.nlm .nihgov/entrez/ query.fcgi?itool=abstractplus&db=pubmed&cmd=Retrieve&dopt=abstractplus&list_uids=2166249

Plaitakis, A. (1990).Glutamate dysfunction and selective motor neuron degeneration in amyotrophic lateral sclerosis: A hypothesis Annals of Neurology 28, I (1) 3-8. Retrieved May 25, 2007, from http://www3.interscience.wiley.com/cgi-bin/abstract/ 109678932/ABSTRACT

Rao, K.S., McConnell, R.G., & Waisman, H.A. (1972). 52 week oral toxicity study in the infant monkey SC-18862. Retrieved February 19, 2008, from http://www.dorway.com/ raoreport.pdf

Posner, H. S. (1975). Biohazards of methanol in proposed new uses. Journal of Toxicology and Environmental Health, (1), 153-171.

Reynolds, A., Lemkey-Johnston, N., Filer Jr., L.J., & Pitkin,R.M., (1971). Monosodium glutamate: absence of hypothalamic lesions after Ingestion by newborn primates, Science, (172), 1342-1344.

Richards, B. J. (2006). The new childhood drug culture. Fight for Your Health. Exposing the FDA’s Betrayal of America. (pp. 21-27) Tucson, Arizona, U.S.A.

Roberts, H.J. (1990). Aspartame (NutraSweet®) Is it safe? Philadelphia: The Charles Press

Roberts, H.J. (1995). Defense against Alzheimer’s disease. Sunshine Sentinel Press, Inc. P.O. Box 8697 west Palm Beach, Fl 33407 fax 407.832.2400

Roberts, H.J. (2000). Aspartame, NutraSweet ® Addiction. The Townsend Letter for Doctors and Patients. 11 Tyler Street, Port Townsend, WA 98368 Phone: 360 385-6021 (pp. 52-57) Retrieved May 26, 2007 from, http://www.dorway.com/tldaddic.html

Roberts, H.J. (2001). Aspartame disease – An ignored epidemic. Sunshine Sentinel Press, Inc. P.O. Box 17799, West Palm Beach, FL 33416

Rothman, S. M. (1985). The neurotoxicity of excitatory amino acids is produced by passive chloride influx’. Departments of Pediatrics, Neurology, and Anatomy and Neurobiology, Washington University School of Medicine, St. Louis, Missouri 63 110 The Journal of Neuroscience 5, (6), 1483-1489.

Rothstein, J. (1996). The ALS newsletter - Muscular Dystrophy Association 1, (8). National Headquarters, 3300 East Sunrise Drive, Tucson, Arizona 85718-3208. Retrieved August 14, 2007 from, http://als.mda.org/publications/als/als1_8.html

Rothstein, J.D., Tsai, G., Kuncl, R.W., Clawson, L., Cornblath, D.R., & Drachman, D.B., et al. (2004). Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis. Annals of Neuroscience 28 (1), 18 – 25. Retrieved January 7, 2007 from, http://www3 .interscience.wiley.com/cgi-bin/abstract/109678935/ ABSTRACT?CRETRY=1&SRETRY=0

Sindou, P., Couratier, P., Barthe, D., & Hugon, J. (1992). A dose-dependent increase of Tau immunostaining is produced by glutamate toxicity in primary neuronal cultures. Brain Research (14), 572(1-2), 242-246. Retrieved May 17, 2006 from, http://www .ncbi.nlm.nih.gov/entrez/ query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1351785&dopt=Abstract

Schapira, A.H., Cooper, J.M., Dexter, D., Clark, J.B. Jennery, P., & Marshen, C.D.(1990). mitochondrial complex I deficiency in Parkinson's disease. Journal of Neurochemistry ;54(3), 823-827. Retrieved May 26, 2007 from, http://www.ncbi.nlm.nih .gov/entrez/ query.fcgi?cmd=Retrieve&db=PubMed&list_uids=2154550&dopt=Abstract

Sheu, K.F., Lai, J.C., & DiLorenzo, J.C., (1988). Pyruvate dehydrogenase complex is inhibited in calcium-loaded cerebrocortical mitochondria.. Biomedical and Life Sciences, 13 (11), 1043-1048.

Sittig, M. (1985). Handbook of toxic and hazardous chemicals and carcinogens. 2nd ed. Noyes Publications. Park Ridge, NJ.

Siesjo, B. K., Bengtsson, F., Grampp, W., & Theander, S. (1989). Calcium, excitotoxins, and neuronal death in the brain. Annals of the New York Academy of Sciences Section: Calcium, Membranes, Aging, and Alzheimer's Disease 568 (1), 234–251.. Retrieved June 16, 2007 from, http://www.blackwell-synergy.com/doi/abs/10.1111/j.1749-6632.1989.tb12513.x?journalCode=nyas

Smith, Q.R. (2000). Transport of glutamate and other amino acids at the blood-brain barrier. Journal of Nutrition.(130),1016S-1022S. Retrieved June 3, 2007, fromhttp://jn.nutrition.org/cgi/content/abstract/130/4/1016S

Sofretti, M., Belpoggi F., Degli, D. D., Esposti, Lambertini, L., & Tibaldi, E., et al. (2005). European Ramazzini Foundation of Oncology and Environmental Sciences, Bologna, Italy Study.First experimental demonstration of the multipotential carcinogenic effects of aspartame administered in the feed to Sprague-Dawley Rats. Retrieved November 17, 2006, from http://www.ehponline.org/docs/2005/8711/abstract.html

South, J. (2003). Excitotoxins, the ultimate brainslayer. The American Academy of Anti-Aging Medicine. Anti-Aging Library. Retrieved June 3, 2007, from http://www.worldhealth .net/p/ 1008,2049.html

Spencer, P.S., Nunn P.B., Hugon, J. Ludolph, A.C., Ross, S.M., & Roy, D.N., et al. (1987). Guam amyotrophic lateral sclerosis-parkinsonism-dementia linked to a plant toxin excitant neurotoxin. Science, 237 (4814), 517-522. Retrieved May 8, 2007 http://www.sciencemag.org/cgi/content/abstract/237/4814/517

Stadtman, E.R. (1992). Protien oxidation and aging. Science, (257), 1220 –1224. Retrieved August 9, 2007 from, http://www.sciencemag.org/cgi/content/abstract/257/5074/1220

Stegink, Lewis D. & Filer L. (1984). Aspartame: Physiology and biochemistry. Marcel Dekker, Inc., N.Y.

Stoddard, M. N. (1995). The deadly deception. Compiled by the Aspartame Consumer Safety Network for volumes of available published information, ACSN, P.O. Box 780634, Dallas, Texas 75378, (800) 969-6050

Tilson, H.A., Zhao, D., Peterson, N.J. et al: (1987). Behavioral and neurological effects. In proceedings of the first international meeting on dietary phenylalanine and brain function. Edited by R.J. Wurtman and E. Ritter-Walker, Washington, D.C., pp.107-115

Trials of War Criminals before the Nuremberg Military Tribunals under Control Council Law (1949). Washington, D.C.: U.S. Government Printing Office 2 (10), 181-182. Retrieved May 26, 2007, from http://ohsr.od.nih.gov/guidelines/nuremberg.html

U.S. Department of Health and Human Services, (1993). Hazardous Substances Data Bank (HSDB, online database). National Toxicology Information Program, National Library of Medicine, Bethesda, MD.

Trojanowski, J.D. (1999). Alzheimer’s disease, Parkinson’s disease and related brain disorders: Overview for patients and caregivers. University of Pennsylvania Health System. Center for Neurodegenerative Disease Research. Retrieved February 4, 2007, from http://www.uphs.upenn.edu/cndr/Research/pages/ADPD.html

US Congressional Record, (1985). 131, (106), S10826-S10827

U.S. Environmental Protection Agency – Methanol. Hazard summary-created in April 1992; Revised in January 2000. Retrieved April 7 2007 from, http://www.epa.gov/ttn/ atw/hlthef/methanol.html

Van Harreveld, A.& Mendelson, M (1959). Glutamate-induced contractions in crustacean muscle. Journal of Cellular Computional Physics (54) 85-94. Retrieved on August 2, 2007, from http://www3.interscience.wiley.com/cgi-bin/abstract/ 109909151/ ABSTRACT?CRETRY=1&SRETRY=0

Watkins, J.C. & Evans, R.H. (1981). Excitatory amino acid transmitters. The Annual Review of Pharmacology and Toxicology (21),165-204.

Woodrow, M. (1984) Aspartame: Methanol and the public health. Journal of Applied Nutrition, 36, (1), 1984, (pp. 44).

Whetsell,W. & Shapira, N. (1993). Biology of disease. Neuroexcitation, excitotoxicity and human neurological disease, Lab Invest 68: 372-87

Whitehouse, P.J. (1986). Understanding the etiology of Alzheimer's disease. Current approaches. Neurology Clinic 4(2), 427-437. Retrieved May 18, 2007, from http://www.ncbi.nlm .nih.gov/entrez/query.fcgi?CMD=Display&DB=pubmed

Wilson, S. (1985). Sweet suspicions. Television broadcast and interviews regarding aspartame. Transcript in Congressional Record (1985b, page S10826-S10827) Retrived February 20, 2008, from http://www.holisticmed.com/aspartame/history.faq

Winn, P., Clark, A.,Hastings, M.,Clark, J., Latimer, M., & Rugg, E.,  et al. (1990). Excitotoxic lesions of the lateral hypothalamus made by N-methyl-d-aspartate in the rat: behavioural, histological and biochemical analyses. Experimental Brain Research. Springer Berlin/Heidelberg.82, (3), 628-636. Retrieved June 3, 2007, from http://www .springerlink .com/content/rh07t271416x2396/

Winstead, E.R. (2003). Anti-inflammatory drugs restore neuron growth in the brain. Genome News Network. Retrieved June 9, 2007, from http://www.genomenewsnetwork .org/articles/11_03/brain.shtml

Wu D.C., Re D.B., Nagai M., Ischiropoulos H., & Przedborski S. (2006). The inflammatory NADPH oxidase enzyme modulates motor neuron degeneration in amyotrophic lateral sclerosis mice. Proceedings of National Academy of Sciences U S A. (103), 32

Wurtman, R.J. (1985). Aspartame: Possible effect on seizure susceptibility. Lancet (2), 1060.

Wurtman, R.J. (1987). Dietary phenylalanine and brain function. Proceedings of the First International Meeting on Dietary Phenylalanine and Brain Function, Washington DC USA, 8 May 1987. Retrieved May 13, 2007, from http://www.taxtyranny.ca/images/ HTML/Aspartame/Articles/dangerousfood.doc

Wurtman, R. J. & Maher, T. J. (1987). Effects of aspartame on the brain: Neurologic effects of aspartame. Presented at the symposium: Sweeteners: Health Effects, Naylor-Dana Foundation, New York.

Wyss-Coray, T. & Mucke, L. (2002). Inflammation in neurodegenerative disease - A double-edged sword. Gladstone Institute of Neurological Disease and Department of Neurology, Retrieved June 9, 2007, from http://www.sciencedirect.com/ science?_ob=ArticleURL&_udi=B6WSS-46FS7D0-5&_user=5778172&_coverDate=08%2F01%2F2002&_rdoc=1&_fmt=&_orig=search&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=5778172&md5=5be44aaef0fe4b991b10963d9a08d2d4#fn1

Yasko, A. (2003). Neurological inflammation: An approach to reversing the process. Neurological Research Institute. Retrieved June 9, 2007, from http://www.holistichealth .com/Publications/EFE50725-9744-4927-ABCE-CA2C5C540020.html

 

Back to Table of Contents